Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has filed a request for regulatory clearance to initiate a Phase 1/2a clinical trial of ARO-DIMER-PA, the company’s ...

One of the most frequently flagged issues during health checkups is dyslipidemia, which includes hyperlipidemia?a condition characterized by high ...

Arrowhead (ARWR) announced that it has filed a request for regulatory clearance to initiate a Phase 1/2a clinical trial of ARO-DIMER-PA, the ...

I am looking for information on the use of inositol hexaniacinate ("no-flush niacin") in the treatment of hyperlipidemia. Most of the information I have been able to find is anecdotal. I understand ...

Researchers have uncovered a simple magnesium-based score that could help identify which high-cholesterol patients are most likely to face deadly heart problems, years before symptoms appear. Study: ...

What is the significance of asymptomatic CK elevation in combination therapy of hyperlipidemia with statin/Niaspan (niacin extended-release tablets)? I have a patient whose lipids were suboptimally ...

The findings underscore that pregnancy is “a crucial window of opportunity to optimize cardiovascular health,” researchers ...

Machine learning models, particularly LightGBM, effectively predict hyperlipidemia in PLWH on HAART for six months, with high accuracy and area under curve values. The study's limitations include ...

Research led by Baylor College of Medicine has shown that a new therapy significantly reduces triglyceride levels in individuals with mixed hyperlipidemia – elevations of triglycerides and cholesterol ...

Please provide your email address to receive an email when new articles are posted on . “PCOS patients are at increased risk of metabolic conditions, even patients who were in the non-obese range,” ...

Hyperlipidemia describes a condition where the amount of lipids in the blood is too high. It can include several conditions, but usually refers to a high cholesterol and triglyceride level. At healthy ...

Medicines use review in renal cancer: How are we doing? What could we do better? Background: To our knowledge effects of sunitinib on serum lipids metabolism are not described. Here we report about ...